Conmed (CNMD) FCF Payout Ratio Growth (1y) (2013 - 2025)
Conmed (CNMD) FCF Payout Ratio Growth (1y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -16.90% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -8.00% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 0.45% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -88.24% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -11.29% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 27.54% |
| 10 | Conmed | 1.54 Bn | 1.50 Bn | 197.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.46% |
| Sep 30, 2025 | -1.06% |
| Jun 30, 2025 | 70.46% |
| Mar 31, 2025 | -27.94% |
| Dec 31, 2024 | 31.75% |
| Sep 30, 2024 | -14.51% |
| Jun 30, 2024 | -43.81% |
| Mar 31, 2024 | 130.18% |
| Dec 31, 2023 | 133.81% |
| Sep 30, 2023 | -52.50% |
| Jun 30, 2023 | -39.05% |
| Mar 31, 2023 | 56.95% |
| Dec 31, 2022 | -284.92% |
| Sep 30, 2022 | -14.00% |
| Jun 30, 2022 | 143.63% |
| Mar 31, 2022 | -682.46% |
| Dec 31, 2021 | -43.30% |
| Sep 30, 2021 | 105.84% |
| Jun 30, 2021 | -94.18% |
| Mar 31, 2021 | -95.27% |